![Walter Blättler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Walter Blättler
Presidente en
35Pharma, Inc.
.
Perfil
Walter A. Blättler was the founder of Semma Therapeutics, Inc. founded in 2015, where he held the title of Vice President-Manufacturing.
He currently holds the position of Chairman at Formation Biologics Corp.
and 35Pharma, Inc. Dr. Blättler's former positions include Director-Pre Clinical Development at Proterris (Portugal) -.
Investigação e Desenvolvimento from 2009 to 2011, Director at Bristol-Myers Squibb FCT bêta, Inc. from 2014 to 2020, Executive Vice President-Science & Technology at ImmunoGen, Inc. from 1987 to 2007, Independent Member-Supervisory Board at MorphoSys AG from 2007 to 2015, and Vice President-Development at CoStim Pharmaceuticals, Inc. from 2012 to 2014.
Dr. Blättler's education includes a graduate degree from Swiss Federal Institute of Technology in 1973 and a doctorate degree from Swiss Federal Institute of Technology in 1978.
Cargos activos de Walter Blättler
| Empresas | Cargo | Inicio |
|---|---|---|
35Pharma, Inc.
 35Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in designing and developing of TGF-beta superfamily therapeutics | Presidente | - |
Antiguos cargos conocidos de Walter Blättler.
| Empresas | Cargo | Fin |
|---|---|---|
Bristol-Myers Squibb FCT bêta, Inc.
 Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-tumor activity medication treatment | Director/Miembro de la Junta | 21/09/2020 |
| MORPHOSYS AG | Director/Miembro de la Junta | 08/05/2015 |
CoStim Pharmaceuticals, Inc.
 CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | Corporate Officer/Principal | 01/01/2014 |
Proterris (Portugal) - Investigação e Desenvolvimento
 Proterris (Portugal) - Investigação e Desenvolvimento Pharmaceuticals: GenericHealth Technology Develops small-molecule drugs for the treatment of inflammation-related diseases | Corporate Officer/Principal | 01/01/2011 |
| IMMUNOGEN, INC. | Corporate Officer/Principal | 05/03/2007 |
Formación de Walter Blättler.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
68
Relaciones de 1er grado
9
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 9 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Swiss Federal Institute of Technology
 Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proterris (Portugal) - Investigação e Desenvolvimento
Proterris (Portugal) - Investigação e Desenvolvimento Pharmaceuticals: GenericHealth Technology Develops small-molecule drugs for the treatment of inflammation-related diseases | Health Technology |
Bristol-Myers Squibb FCT bêta, Inc.
Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-tumor activity medication treatment | Health Technology |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | Health Technology |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative therapies for patients who currently depend on insulin injections | Health Technology |
Formation Biologics Corp.
 Formation Biologics Corp. Miscellaneous Commercial ServicesCommercial Services Operates clinical stage company that designs and develops bio therapeutics for treatment of cancer & fibrotic diseases | Commercial Services |
35Pharma, Inc.
35Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in designing and developing of TGF-beta superfamily therapeutics | Health Technology |
- Bolsa de valores
- Insiders
- Walter Blättler
Elige MarketScreener 
